The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Predictors and outcomes of scleroderma renal crisis: The high‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis trial
Abstract
Objective: The reported frequency of scleroderma M01‐R renal crisis (SRC) in diffuse systemic sclerosis (SSc; scleroderma) is 15–20%. Early use of angiotensin‐converting enzyme (ACE) inhibitors has markedly improved outcome. The present analysis reexamines the prognostic factors for and outcome of SRC in a prospective cohort of patients with early diffuse SSc. Methods: We retrospectively evaluated the cohort of SSc patients who participated in the High‐Dose Versus Low‐Dose D‐Penicillamine in Early Diffuse SSc trial. Patients with diffuse cutaneous scleroderma were enrolled if their disease duration was <18 months. Because the trial failed to show a difference between treatment groups, the data were pooled. Results: One hundred thirty‐four SSc patients entered the observation period a mean ± SD of 0.8 ± 0.3 years after onset of SSc. SRC occurred in 18 patients a mean ± SD of 0.9 ± 1.1 years after entry. During a mean ± SD 4.0 ± 1.1 years of followup after entry, 9 of the 18 patients died (mean ± SD 0.6 ± 0.9 years after SRC onset). Baseline characteristics that predicted SRC included a modified Rodnan skin thickness score of ≥20 (P < 0.01), enlarged cardiac silhouette on radiograph (P = 0.04), large joint contractures (wrist, elbow, knee) (P = 0.008), and prednisone use at entry (P = 0.01). Baseline characteristics that did not predict SRC included age, sex, race, Health Assessment Questionnaire score, fist closure, handspread, lung involvement, muscle weakness, erythrocyte sedimentation rate, and platelet count. In 5 of 10 subjects for whom at least 2 sequential skin scores were available, skin scores increased significantly (P = 0.012) in the 6 months before onset of SRC. Conclusion: SRC occurred in 13% of patients soon (mean 11 months) after entry into the cohort. Predictors of SRC identified in this study included higher than average skin score, prednisone use at study entry, large joint contractures, and heart enlargement. Our data suggest, however, that low‐dose prednisone alone was not associated with the onset of SRC, except in the appropriate clinical setting. Although ACE inhibitors and dialysis are now readily available, SRC continues to be associated with poor survival (in this study, 50% of patients with SRC died).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A note on a general definition of the coefficient of determination
NAGELKERKE, N. J. D. (1991) · Biometrika · doi:10.1093/biomet/78.3.691 · Cited by 5,927
Cited by
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
Self-citationInterstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Kowal-Bielecka, O., Landewé, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096677 · Cited by 619
Self-citationMortality in systemic sclerosis: An international meta-analysis of individual patient data
Ioannidis, J. P. A., Vlachoyiannopoulos, P. G., Haidich, A.-B., Medsger, T. A., Lucas, M., Michet, C. J., Kuwana, M., Yasuoka, H., van den Hoogen, F., te Boome, L., et al. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.031 · Cited by 438
Self-citationScleroderma renal crisis: patient characteristics and long-term outcomes
Penn, H., Howie, A. J., Kingdon, E. J., Bunn, C. C., Stratton, R. J., Black, C. M., Burns, A., & Denton, C. P. (2007) · QJM · doi:10.1093/qjmed/hcm052 · Cited by 427
Metadata
- Authors
- DeMarco, P. J., Weisman, M. H., Seibold, J. R., Furst, D. E., Wong, W. K., Hurwitz, E. L., Mayes, M., White, B., Wigley, F., Barr, W., Moreland, L., Medsger, T. A., Steen, V., Martin, R. W., Collier, D., Weinstein, A., Lally, E., Varga, J., Weiner, S. R., Andrews, B., Abeles, M., & Clements, P. J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-11
- Volume
- 46
- Issue
- 11
- Pages
- 2983-2989
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2010426653
- Cited by
- 225
- References
- 1
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors and outcomes of scleroderma renal crisis: The high‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis trial. https://app.cochat.ai/papers/10.1002/art.10589
- The paper
- DeMarco, P. J., Weisman, M. H., Seibold, J. R., Furst, D. E., Wong, W. K., Hurwitz, E. L., Mayes, M., White, B., Wigley, F., Barr, W., Moreland, L., Medsger, T. A., Steen, V., Martin, R. W., Collier, D., Weinstein, A., Lally, E., Varga, J., Weiner, S. R., . . . Clements, P. J. (2002). Predictors and outcomes of scleroderma renal crisis: The high‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis trial. Arthritis & Rheumatism. https://doi.org/10.1002/art.10589
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.